|
|
10.06.25 - 13:06
|
International Wire Group Acquires Hussey Copper (PR Newswire)
|
|
STAMFORD, Conn., June 10, 2025 /PRNewswire/ -- International Wire Group (IWG), a portfolio company of Olympus Partners and Atlas Holdings, entered into a definitive agreement to purchase Hussey Copper. Headquartered in Leetsdale, Pa., Hussey Copper is a market-leading supplier of copper......
|
|
|
29.05.25 - 15:36
|
Olympus Announces Launch of New Endoscope Drying Cabinet (PR Newswire)
|
|
ScopeLocker Air Offers Flexible Size and Air Options for Space-Conscious Facilities; Olympus to Highlight New Drying Cabinet at Annual SGNA Conference CENTER VALLEY, Pa., May 29, 2025 /PRNewswire/ -- Olympus Corp., a global medical technology company committed to making people's lives......
|
|
|
22.05.25 - 20:54
|
AMA Establishes CPT Codes for Minimally Invasive ESD Procedure (PR Newswire)
|
|
CENTER VALLEY, Pa., May 22, 2025 /PRNewswire/ -- Olympus Corporation, a global medical technology company committed to making people's lives healthier, safer, and more fulfilling, announced today the American Medical Association (AMA) Current Procedural Terminology (CPT®) Editorial Panel......
|
|
|
13.05.25 - 13:24
|
Olympus Corp. Profit Retreats In Full Year (AFX)
|
|
TOKYO (dpa-AFX) - Olympus Corp. (OCPNY.PK) revealed earnings for full year that decreased from the same period last yearThe company's earnings came in at JPY117.855 billion, or JPY102.80 per share......
|
|
|
01.05.25 - 19:51
|
Olympus Demonstrates New AI Endoscopy Solution at DDW® (PR Newswire)
|
|
The OLYSENSE Platform Aims to Strengthen Clinical Decision-Making by Leveraging Cloud-based Connectivity and AI Computing CENTER VALLEY, Pa., May 1, 2025 /PRNewswire/ -- Olympus, a global medical technology company committed to making people's lives healthier, safer and more fulfilling,......
|
|
27.04.25 - 22:06
|
OLYMPUS Long-Term Follow-Up Study Reports Nearly Four-Year Duration of Response in Subset of Patients with Low-Grade Upper Tract Urothelial Cancer Who Achieved a Complete Response to Initial JELMYTO Treatment (Business Wire)
|
|
Data Presented at the 2025 American Urological Association Annual Meeting in Las Vegas, Nevada
PRINCETON, N.J.--(BUSINESS WIRE)--UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing novel solutions that treat urothelial and specialty cancers, today highlights a duration of response of nearly four years from a long-term follow-up study with JELMYTO® (mitomycin) for pyelocalyceal solution, which is FDA-approved for the treatment of low-grade upper tract urothelial cancer (LG-UTUC) in adult patients.
Among patients from the OLYMPUS trial who achieved a complete response after primary chemoablation with JELMYTO (n=41), the median duration of response was 47.8 months, irrespective of whether their cancer was new-onset or recurrent (median follow-up 28.1 months [95% CI 13.1, 57.5]). Of these patients, 21 had new-onset UTUC, and 20 had recurrent UTUC at baseline; there were no significant differences in durability between groups, with 8 patients in each group experien...
|
|
|
|
|
|
|
|
|
|
08.04.25 - 12:03
|
Monroe Capital Supports Olympus Partners′ Acquisition of PAI Pharma (Business Wire)
|
|
CHICAGO--(BUSINESS WIRE)--Monroe Capital LLC (“Monroe”) announced it acted as joint lead arranger on the funding of a senior credit facility to support the acquisition of PAI Pharma (“PAI”) by Olympus Partners.
Founded in 1968 and based in Greenville, SC, PAI is a leading US oral generic liquids manufacturer of ready-to-dose cups and oral liquids bottles. PAI offers the broadest portfolio of generic oral liquid medicines in the industry, supporting retail chains, independent pharmacies, hospitals, long-term care facilities and government agencies.
About Monroe Capital
Monroe Capital LLC (“Monroe”) is a premier asset management firm specializing in private credit markets across various strategies, including direct lending, technology finance, venture debt, alternative credit solutions, structured credit, real estate and equity. Since 2004, the firm has been successfully providing capital solutions to clients in the U.S. and Canada. Monroe prides itself on being a value-added and user-friendly p...
|
|